Mealey's (March 17, 2022, 1:38 PM EDT) -- WASHINGTON, D.C. — In a March 16 order, the Federal Circuit U.S. Court of Appeals said it will not revisit a November holding that declared a patented method for treating multiple sclerosis (MS) invalid for inadequate written description....